Human papillomavirus and gene mutations in head and neck squamous carcinomas

ANZ Journal of Surgery

Volumn 82, Issue 5, 2012, Pages 362-366

  Friedland, Peter ^a   Thomas, Anitha ^a,b   Naran, Anupam ^b   Amanuel, Benhur ^a,b   Grieu Iacopetta, Fabienne ^b   Carrello, Amerigo ^b   Harnett, Gerald ^b   Meyer, Christine ^c   Phillips, Michael ^d  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b PATHWEST LABORATORY MEDICINE   (Australia)

^c SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^d UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Gene mutations; Histopathology; HPV 16; P16; Tonsillar neoplasm

Indexed keywords

B RAF KINASE; BRAF PROTEIN, HUMAN; EPIDERMAL GROWTH FACTOR RECEPTOR; KRAS PROTEIN, HUMAN; ONCOPROTEIN; RAS PROTEIN; VIRUS DNA;

ALPHAPAPILLOMAVIRUS; ARTICLE; AUSTRALIA; GENETICS; HEAD AND NECK TUMOR; HUMAN; MUTATION; PAPILLOMAVIRUS INFECTION; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE; VIROLOGY;

ALPHAPAPILLOMAVIRUS; CARCINOMA, SQUAMOUS CELL; DNA, VIRAL; GENES, P16; GENES, P53; HEAD AND NECK NEOPLASMS; HUMANS; MUTATION; PAPILLOMAVIRUS INFECTIONS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS B-RAF; RAS PROTEINS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RETROSPECTIVE STUDIES; WESTERN AUSTRALIA;

EID: 84860244031     PISSN: 14451433     EISSN: 14452197     Source Type: Journal    
DOI: 10.1111/j.1445-2197.2011.05791.x     Document Type: Article

References (25)

1. Jemal A, Siegel R, Ward E etal. Cancer statistics, 2008. CA Cancer J. Clin. 2008; 58: 71-96.
2. Spitz MR. Epidemiology and risk factors for head and neck cancer. Semin. Oncol. 1994; 21: 281-8.
3. Tran N, Rose BR, O'Brien CJ. Role of human papillomavirus in the etiology of head and neck cancer. Head Neck 2007; 29: 64-70.
4. Ragin CC, Taioli E. Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: review and meta-analysis. Int. J. Cancer 2007; 121: 1813-20.
5. Hobbs CG, Sterne JA, Bailey M, Heyderman RS, Birchall MA, Thomas SJ. Human papillomavirus and head and neck cancer: a systematic review and meta-analysis. Clin. Otolaryngol. 2006; 31: 259-66.
6. Dayyani F, Etzel CJ, Liu M etal. Meta-analysis of the impact of human papillomavirus (HPV) on cancer risk and overall survival in head and neck squamous cell carcinomas (HNSCC). Head Neck Oncol. 2010; 2: 15.
7. Fakhry C, Westra WH, Li S etal. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J. Nat. Cancer Int. 2008; 100: 261-9.
8. Ang K, Harris J, Wheeler R etal. Human papillomavirus and survival of patients with oropharyngeal cancer. N. Eng. J. Med. 2010; 363: 24-35.
9. Allen C, Lewis J, El-Mofty S, Haughey B, Nussenbaum B. Human papillomavirus and oropharynx cancer: biology, detection and clinical implications. Laryngoscope 2010; 120: 1756-72.
10. Perez-Ordonez B, Beauchemin M, Jordan RCK. Molecular biology of squamous cell carcinoma of the head and neck. J. Clin. Pathol. 2006; 59: 445-53.
11. Li W, Thompson CH, Cossart YE etal. The expression of key cell cycle markers and presence of human papillomavirus in squamous cell carcinoma of the tonsil. Head Neck 2004; 26: 1-9.
12. Kumar B, Cordell KG, Lee JS etal. Response to therapy and outcome in oropharyngeal cancer are associated with biomarkers including HPV, EGFR, gender and smoking. Int. J. Radiat. Oncol. Biol. Phys. 2007; 1: s109-s111.
13. Smith EM, Rubenstein LM, Hoffman H etal. Human papillomavirus, p16 and p53 expression associated with survival of head and neck cancer. Infect. Agents Cancer 2010; 5: 1-10.
14. Westra WH, Taube JM, Poeta ML etal. inverse relationship between human Papillomavirus-16 infection and disruptive p53 gene mutations in squamous cell carcinoma of the head and neck. Clin. Cancer Res. 2008; 14: 366-9.
15. Weber A, Langhanki L, Sommerer F etal. Mutations of the BRAF gene in squamous cell carcinoma of the head and neck. Oncogene 2003; 22: 4757-9.
16. Al Sheikh Ali M, Gunduz M, Gunduz E etal. Lack of B-RAF mutations in head and neck squamous cell carcinoma. Folia Biol. 2008; 54: 157-61.
17. Loeffler-Ragg J, Witsch-Baumgartner M, Tzankov A etal. Low incidence of mutations in EGFR kinase domain in Caucasian patients with head and neck squamous cell carcinoma. Eur. J. Cancer 2006; 42: 109-1.
18. Na I, Kang H, Cho S etal. EGFR mutations and human papillomavirus in squamous cell carcinoma of tongue and tonsil. Eur. J. Cancer 2007; 43: 520-6.
19. Lee JW, Soung YH, Kim SY etal. Somatic mutations of EGFR gene in squamous cell carcinoma of the head and neck. Clin. Cancer Res. 2005; 11: 2879-82.
20. Bonner JA, Harari PM, Giralt J etal. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N. Engl. J. Med. 2006; 354: 567-78.
21. Tejani MA, Cohen RB, Mehra R. The contribution of cetuximab in the treatment of recurrent and or metastatic head and neck cancer. Biologics 2010; 4: 173-85.
22. Brunner K, Fischer CA, Driemel O, Hartmann A, Brockhoff G, Schwarz S. EGFR (HER) family protein expression and cytogenetics in 219 squamous cell carcinomas of the upper respiratory tract: ERBB2 over expression independent prediction of poor prognosis. Anal. Quant. Cytol. Histol. 2010; 32: 78-89.
23. Lacopetta B, Grieu F. Routine detection of the replication error phenotype in clinical tumour specimens using fluorescence-SSCP. Biotechniques 2000; 28: 566-70.
24. Loeffler-Ragg J, Witsch-Baumgartner M, Tzankov A etal. Low incidence of mutations in EGFR kinase domain in Caucasian patients with head and neck squamous cell carcinoma. Eur. J. Cancer 2006; 42: 109-11.
25. Weber A, Langhank Li L, Sommerer F, Annett Markwarth A etal. Mutations of the BRAF gene in squamous cell carcinoma of the head and neck. Oncogene 2003; 22: 4757-9.